Perspectives for pharmaceutical screening at XFEL sources using the example of Lassa virus endonuclease.

Falke S, Reinke PYA, Rosenberg D, Fischer P, Meyer J, Galchenkova M, Tolstikova A, Mariani V, Senst JM, Lewe P, Witt S, Wagner A, Chapman HN, Hunter M, Günther S, Meents A

Open source

DOI: 10.1107/s2059798326009435
Published: 2026 Oct 1
Container: Acta crystallographica. Section D, Structural biology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1107/s2059798326009435,
  title = {Perspectives for pharmaceutical screening at XFEL sources using the example of Lassa virus endonuclease.},
  author = {Falke S and Reinke PYA and Rosenberg D and Fischer P and Meyer J and Galchenkova M and Tolstikova A and Mariani V and Senst JM and Lewe P and Witt S and Wagner A and Chapman HN and Hunter M and Günther S and Meents A},
  year = {2026},
  journal = {Acta crystallographica. Section D, Structural biology},
  doi = {10.1107/s2059798326009435},
  url = {https://doi.org/10.1107/s2059798326009435}
}

RIS

TY  - JOUR
TI  - Perspectives for pharmaceutical screening at XFEL sources using the example of Lassa virus endonuclease.
AU  - Falke S
AU  - Reinke PYA
AU  - Rosenberg D
AU  - Fischer P
AU  - Meyer J
AU  - Galchenkova M
AU  - Tolstikova A
AU  - Mariani V
AU  - Senst JM
AU  - Lewe P
AU  - Witt S
AU  - Wagner A
AU  - Chapman HN
AU  - Hunter M
AU  - Günther S
AU  - Meents A
PY  - 2026
JO  - Acta crystallographica. Section D, Structural biology
DO  - 10.1107/s2059798326009435
UR  - https://doi.org/10.1107/s2059798326009435
ER  -

APA

S, F., PYA, R., D, R., P, F., J, M., M, G., A, T., V, M., JM, S., P, L., S, W., A, W., HN, C., M, H., S, G., & A, M. (2026). Perspectives for pharmaceutical screening at XFEL sources using the example of Lassa virus endonuclease.. Acta crystallographica. Section D, Structural biology. https://doi.org/10.1107/s2059798326009435

Source records

pubmed · retrieved 2026-09-25T23:22:52.877Z